LXEO
LXEO
NASDAQ · Biotechnology

Lexeo Therapeutics Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$5.83
+0.01 (+0.17%)
As of May 10, 10:20 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 16 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +697.1% upside
Low Target $27.16
Average Target $46.47
High Target $57.70
Current Price $5.83
Current
$5.83
Target
$46.47
$27.16 $46.47 avg $57.70
Scenario Analysis
Bear Case
$27.16
365.9%
Low target
Base Case
$46.47
+697.1%
Avg target
Bull Case
$57.70
+889.7%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$10.99
-47.0% from high
52-Week Low
$2.43
+139.9% from low
Target vs 52W High
$46.47
+322.8% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-0.32
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%